• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双腔植入式心脏复律除颤器检测心房颤动和心房扑动。全球Jewel AF研究人员。

Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators.

作者信息

Swerdlow C D, Schsls W, Dijkman B, Jung W, Sheth N V, Olson W H, Gunderson B D

机构信息

Cedars-Sinai Medical Center, Los Angeles, CA, USA.

出版信息

Circulation. 2000 Feb 29;101(8):878-85. doi: 10.1161/01.cir.101.8.878.

DOI:10.1161/01.cir.101.8.878
PMID:10694527
Abstract

BACKGROUND

To distinguish prolonged episodes of atrial fibrillation (AF) that require cardioversion from self-terminating episodes that do not, an atrial implantable cardioverter-defibrillator (ICD) must be able to detect AF continuously for extended periods. The ICD should discriminate between atrial tachycardia/flutter (AT), which may be terminated by antitachycardia pacing, and AF, which requires cardioversion.

METHODS AND RESULTS

We studied 80 patients with AT/AF and ventricular arrhythmias who were treated with a new atrial/dual-chamber ICD. During a follow-up period lasting 6+/-2 months, we validated spontaneous, device-defined AT/AF episodes by stored electrograms in all patients. In 58 patients, we performed 80 Holter recordings with telemetered atrial electrograms, both to validate the continuous detection of AT/AF and to determine the sensitivity of the detection of AT/AF. Detection was appropriate in 98% of 132 AF episodes and 88% of 190 AT episodes (98% of 128 AT episodes with an atrial cycle length <300 ms). Intermittent sensing of far-field R waves during sinus tachycardia caused 27 inappropriate AT/AF detections; these detections lasted 2.6+/-2.0 minutes. AT/AF was detected continuously in 27 of 28 patients who had spontaneous episodes of AT/AF (96%). The device memory recorded 90 appropriate AT/AF episodes lasting >1 hour, for a total of 2697 hours of continuous detection of AT/AF. During Holter monitoring, the sensitivity of the detection of AT/AF (116 hours) was 100%; the specificity of the detection of non-AT/AF rhythms (1290 hours) was 99.99%. Of 166 appropriate episodes detected as AT, 45% were terminated by antitachycardia pacing.

CONCLUSIONS

A new ICD detects AT/AF accurately and continuously. Therapy may be programmed for long-duration AT/AF, with a low risk of underdetection. Discrimination of AT from AF permits successful pacing therapy for a significant fraction of AT.

摘要

背景

为了区分需要心脏复律的持续性心房颤动(AF)发作和可自行终止的发作,植入式心房心律转复除颤器(ICD)必须能够长时间持续检测AF。ICD应能区分可能通过抗心动过速起搏终止的房性心动过速/心房扑动(AT)和需要心脏复律的AF。

方法与结果

我们研究了80例患有AT/AF和室性心律失常并接受新型心房/双腔ICD治疗的患者。在为期6±2个月的随访期间,我们通过所有患者存储的心电图验证了设备定义的自发性AT/AF发作。在58例患者中,我们进行了80次带有遥测心房电图的动态心电图记录,以验证AT/AF的持续检测并确定AT/AF检测的敏感性。在132次AF发作中有98%以及190次AT发作中有88%(心房周期长度<300 ms的128次AT发作中有98%)检测正确。窦性心动过速期间对远场R波的间歇性感知导致27次不适当的AT/AF检测;这些检测持续2.6±2.0分钟。在28例有自发性AT/AF发作的患者中,27例(96%)持续检测到AT/AF。设备存储器记录了90次持续>1小时的适当AT/AF发作,AT/AF持续检测总计2697小时。在动态心电图监测期间,AT/AF检测(116小时)的敏感性为100%;非AT/AF心律检测(1290小时)的特异性为99.99%。在检测为AT的166次适当发作中,45%通过抗心动过速起搏终止。

结论

新型ICD能准确持续地检测AT/AF。对于长时间的AT/AF可设置治疗程序,漏检风险低。区分AT和AF可使相当一部分AT成功进行起搏治疗。

相似文献

1
Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators.双腔植入式心脏复律除颤器检测心房颤动和心房扑动。全球Jewel AF研究人员。
Circulation. 2000 Feb 29;101(8):878-85. doi: 10.1161/01.cir.101.8.878.
2
Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator.双腔植入式心脏复律除颤器治疗室性心律失常患者时起搏治疗对房性快速性心律失常的疗效
Circulation. 2001 Aug 21;104(8):887-92. doi: 10.1161/hc3301.094739.
3
Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies.具备心律失常治疗功能的可植入设备中房性快速性心律失常检测的准确性
Pacing Clin Electrophysiol. 2004 Jul;27(7):983-92. doi: 10.1111/j.1540-8159.2004.00569.x.
4
Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias.使用双腔植入式心脏复律除颤器治疗房性快速性心律失常的临床经验。
J Cardiovasc Electrophysiol. 2001 Nov;12(11):1247-53. doi: 10.1046/j.1540-8167.2001.01247.x.
5
Diagnosis and therapy of atrial tachyarrhythmias in the dual chamber implantable cardioverter defibrillator.双腔植入式心脏复律除颤器中心房快速性心律失常的诊断与治疗
J Cardiovasc Electrophysiol. 2000 Nov;11(11):1196-205. doi: 10.1046/j.1540-8167.2000.01196.x.
6
Discrimination of sinus rhythm, atrial flutter, and atrial fibrillation using bipolar endocardial signals.利用双极心内膜信号鉴别窦性心律、心房扑动和心房颤动。
J Cardiovasc Electrophysiol. 1998 Jul;9(7):689-95. doi: 10.1111/j.1540-8167.1998.tb00955.x.
7
Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator.新型植入式双腔心脏复律除颤器患者中晚期心房起搏治疗心房快速性心律失常的安全性和有效性
J Am Coll Cardiol. 2002 Nov 6;40(9):1653-9. doi: 10.1016/s0735-1097(02)02345-8.
8
Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.快速心房起搏终止药物难治性心房颤动的有效性:双腔植入式心脏复律除颤器试验结果
Card Electrophysiol Rev. 2003 Dec;7(4):341-4. doi: 10.1023/B:CEPR.0000023134.41562.79.
9
Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system.新型双腔植入式心脏复律除颤器系统的全球临床经验。
J Cardiovasc Electrophysiol. 2001 May;12(5):521-8. doi: 10.1046/j.1540-8167.2001.00521.x.
10
[Usefulness of a VDD defibrillation electrode in recording atrial electrograms during atrial flutter and atrial fibrillation].[VDD除颤电极在心房扑动和心房颤动时记录心房电图中的应用价值]
Herz. 2001 Feb;26(1):40-8. doi: 10.1007/pl00002005.

引用本文的文献

1
Incidence of atrial fibrillation in patients with an insertable cardiac monitor and symptomatic heart failure.植入式心脏监测器与症状性心力衰竭患者的心房颤动发生率
ESC Heart Fail. 2025 Jun;12(3):1693-1702. doi: 10.1002/ehf2.15180. Epub 2024 Dec 9.
2
Association of Atrial Fibrillation Burden and Mortality Among Patients With Cardiac Implantable Electronic Devices.心房颤动负荷与植入心脏电子设备患者的死亡率之间的关系。
Circulation. 2024 Jul 30;150(5):350-361. doi: 10.1161/CIRCULATIONAHA.124.069757. Epub 2024 Jun 28.
3
Temporal Association Between Atrial Fibrillation Burden in Cardiac Implantable Electronic Devices and the Risk of Heart Failure Hospitalization.
心脏植入式电子设备中房颤负担与心力衰竭住院风险的时间关联。
Circ Arrhythm Electrophysiol. 2024 Aug;17(8):e012842. doi: 10.1161/CIRCEP.124.012842. Epub 2024 Jun 28.
4
JCS/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias.《日本循环学会/日本心律学会2021年心律失常非药物治疗指南重点更新》
J Arrhythm. 2022 Jan 7;38(1):1-30. doi: 10.1002/joa3.12649. eCollection 2022 Feb.
5
Atrial Fibrillation Burden Signature and Near-Term Prediction of Stroke: A Machine Learning Analysis.心房颤动负荷特征与卒中的近期预测:一项机器学习分析
Circ Cardiovasc Qual Outcomes. 2019 Oct;12(10):e005595. doi: 10.1161/CIRCOUTCOMES.118.005595. Epub 2019 Oct 15.
6
Rate Control in Atrial Fibrillation: Methods for Assessment, Targets for Ventricular Rate during AF, and Clinical Relevance for Device Therapy.心房颤动的心率控制:评估方法、房颤期间心室率目标以及器械治疗的临床意义
J Atr Fibrillation. 2013 Jun 30;6(1):791. doi: 10.4022/jafib.791. eCollection 2013 Jun-Jul.
7
[Implantable loop recorder in atrial fibrillation and after catheter ablation].[植入式循环记录仪在心房颤动及导管消融术后的应用]
Herzschrittmacherther Elektrophysiol. 2016 Dec;27(4):355-359. doi: 10.1007/s00399-016-0471-1. Epub 2016 Nov 10.
8
ICD discrimination of SVT versus VT with 1:1 V-A conduction: A review of the literature.1:1室房传导时室上性心动过速与室性心动过速的ICD鉴别:文献综述
Indian Pacing Electrophysiol J. 2016 Feb 12;15(5):236-44. doi: 10.1016/j.ipej.2016.02.006. eCollection 2015 Sep-Oct.
9
Dual chamber pacing mode in an atrial antitachycardia pacing device without a ventricular lead - A necessary evil.
Indian Pacing Electrophysiol J. 2015 Jul 29;15(2):133-7. doi: 10.1016/j.ipej.2015.07.012. eCollection 2015 Mar-Apr.
10
Clinical benefit, survival and adverse events in patients with implantable cardioverter defibrillators: the initial Rotterdam experience.植入式心脏复律除颤器患者的临床获益、生存率及不良事件:鹿特丹的初步经验
Neth Heart J. 2001 Sep;9(6):216-221.